Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Recent studies have implicated fatty acid-dependent activation of the serine kinase IKKβ, which plays a key role in tissue inflammation, in the pathogenesis of insulin resistance. High doses of salicylates have recently been shown to inhibit IKKβ activity and might therefore ameliorate insulin resistance and improve glucose tolerance in patients with type 2 diabetes. To test this hypothesis, we studied nine type 2 diabetic subjects before and after 2 weeks of treatment with aspirin (∼7 g/d). Subjects underwent mixed-meal tolerance tests and hyperinsulinemic-euglycemic clamps with [6,6-2H2]glucose to assess glucose turnover before and after treatment. High-dose aspirin treatment resulted in a ∼25% reduction in fasting plasma glucose, associated with a ∼15% reduction in total cholesterol and C-reactive protein, a ∼50% reduction in triglycerides, and a ∼30% reduction in insulin clearance, despite no change in body weight. During a mixed-meal tolerance test, the areas under the curve for plasma glucose and fatty acid levels decreased by ∼20% and ∼50%, respectively. Aspirin treatment also resulted in a ∼20% reduction in basal rates of hepatic glucose production and a ∼20% improvement in insulin-stimulated peripheral glucose uptake under matched plasma insulin concentrations during the clamp. In conclusion, these data support the hypothesis that IKKβ represents a new target for treating type 2 diabetes mellitus.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast, inhibition or inactivation of JNK (18,26) or IKK (22,24,25,27) improves insulin sensitivity in various models of insulin resistance in association with reduced inhibitory serine phosphorylation of IRS-1 (18).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [27]
In the citing paper
“Accordingly, KO or inhibition of JNK1 or IKKβ prevents insulin resistance in cell and mouse models (18,22,24,25,87) as well as human models (27) of insulin resistance.”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [27]
In the citing paper
“Moreover, the insulin resistance was ameliorated with salicylates, which also protected against insulin resistance in rodents after acute lipid infusion,127 and reversed insulin resistance in people with type 2 diabetes mellitus.128”
From Lipid-induced insulin resistance: unravelling the mechanism (2010) · cites this paper as [128]
Citations
Cites
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Cellular mechanisms of insulin resistance
Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10583 · Cited by 2,714
Self-citationYuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z.-W., Karin, M., & Shoelson, S. E. (2001) · Science · doi:10.1126/science.1061620 · Cited by 1,884
Self-citationRole of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728
The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β
Yin, M.-J., Yamamoto, Y., & Gaynor, R. B. (1998) · Nature · doi:10.1038/23948 · Cited by 1,590
Mechanism of free fatty acid-induced insulin resistance in humans.
Roden, M., Price, T. B., Perseghin, G., Petersen, K. F., Rothman, D. L., Cline, G. W., & Shulman, G. I. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118742 · Cited by 1,539
Self-citationDresner, A., Laurent, D., Marcucci, M., Griffin, M. E., Dufour, S., Cline, G. W., Slezak, L. A., Andersen, D. K., Hundal, R. S., Rothman, D. L., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5001 · Cited by 1,311
Self-citationGriffin, M. E., Marcucci, M. J., Cline, G. W., Bell, K., Barucci, N., Lee, D., Goodyear, L. J., Kraegen, E. W., White, M. F., & Shulman, G. I. (1999) · Diabetes · doi:10.2337/diabetes.48.6.1270 · Cited by 1,267
Self-citationShulman, G. I., Rothman, D. L., Jue, T., Stein, P., DeFronzo, R. A., & Shulman, R. G. (1990) · New England Journal of Medicine · doi:10.1056/nejm199001253220403 · Cited by 1,248
Self-citationMechanism by which metformin reduces glucose production in type 2 diabetes.
Hundal, R. S., Krssak, M., Dufour, S., Laurent, D., Lebon, V, Chandramouli, V, Inzucchi, S. E., Schumann, W. C., Petersen, K. F., Landau, B. R., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2063 · Cited by 1,052
Self-citation
Research works printed but not linked: 3
- Ebstein, 1877, Berliner Klinische Wochenschrift, 24, 337
- Giugliano, 1982, Diabete Metab, 8, 279
- Shulman, 1990, Am J Physiol, 259, E335
Cited by
Items 301–400 of 554
Hellstrom, H. R. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.05.031 · Cited by 29
Buse, J. B., Polonsky, K. S., & Burant, C. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00031-6 · Cited by 51
Risk factors for stroke in type 2 diabetes mellitus
Asfandiyarova, N. S., Kolcheva, N., Ryazantsev, I., & Ryazantsev, V. E. (2006) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2006.009 · Cited by 32
Ricchi, P., Palma, A. D., Matola, T. D., Apicella, A., Fortunato, R., Zarrilli, R., & Acquaviva, A. M. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.2.407 · Cited by 28
Lin, H., Yen, H., Hsieh, S., An, L., & Shen, K. (2013) · Drug Development Research · doi:10.1002/ddr.21159 · Cited by 27
Zolotnik, I. A., Figueroa, T. Y., & Yaspelkis, B. B. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.08.038 · Cited by 27
Yoshikawa, Y., Adachi, Y., Yasui, H., Hattori, M., & Sakurai, H. (2011) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.59.972 · Cited by 30
Yan, S., Zhang, Q., Zhong, X., Tang, J., Wang, Y., Yu, J., Zhou, Y., Zhang, J., Guo, F., Liu, Y., et al. (2014) · Diabetes · doi:10.2337/db13-1893 · Cited by 26
Ibernón, M., Moreso, F., Moreno‐Navarrete, J. M., Bestard, O., Cruzado, J. M., Grinyo, J. M., Ricart, W., Fernández‐Real, J. M., & Serón, D. (2009) · Transplantation · doi:10.1097/tp.0b013e3181ac8e36 · Cited by 27
Aspirin regulates hepatocellular lipid metabolism by activating AMPK signaling pathway
He, Z., Peng, Y., Duan, W., Tian, Y., Zhang, J., Hu, T., Cai, Y. C., Feng, Y., & Li, G. (2015) · The Journal of Toxicological Sciences · doi:10.2131/jts.40.127 · Cited by 26
Inhibition of NF-κB Reduces Renal Inflammation and Expression of PEPCK in Type 2 Diabetic Mice
Liu, Q., Zhang, L., Zhang, W., Hao, Q., Qiu, W., Wen, Y., Wang, H., & Li, X. (2018) · Inflammation · doi:10.1007/s10753-018-0845-0 · Cited by 29
Effects of sodium salicylate on glucose kinetics and insulin signaling in postpartum dairy cows
Montgomery, S. R., Mamedova, L. K., Zachut, M., Kra, G., Häussler, S., Vaughn, M. A., Gonzalez, J. M., & Bradford, B. J. (2018) · Journal of Dairy Science · doi:10.3168/jds.2018-15312 · Cited by 25
Selective COX2 inhibition improves whole body and muscular insulin resistance in fructose‐fed rats
Hsieh, P., Tsai, H. ‐., Kuo, C., Chan, J. Y. ‐., Shyu, J., Cheng, W.-T., & Liu, T. T. (2008) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2008.02026.x · Cited by 25
Raghavan, R., Laight, D. W., & Cummings, M. H. (2013) · International Journal of Clinical Practice · doi:10.1111/ijcp.12310 · Cited by 25
Obésité, inflammation et insulinorésistance : quel rôle pour les adipokines ?
Antuna-Puente, B., Fève, B., Fellahi, S., & Bastard, J. (2007) · Therapies · doi:10.2515/therapie:2007055 · Cited by 30
Metabolome analysis of effect of aspirin on Drosophila lifespan extension
Song, C., Zhu, C., Wu, Q., Qi, J., Gao, Y., Zhang, Z., Gaur, U., Yang, D., Fan, X., & Yang, M. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2017.04.010 · Cited by 27
Les relations entre obésité, inflammation et insulinorésistance : acquisitions récentes
Fève, B., Bastard, J., & Vidal, H. (2006) · Comptes Rendus Biologies · doi:10.1016/j.crvi.2006.03.020 · Cited by 55
Novel anti-diabetic effect of SCM-198 via inhibiting the hepatic NF-κB pathway in db / db mice
Huang, H., Xin, H., Liu, X., Xu, Y., Wen, D., Zhang, Y., & Zhu, Y. Z. (2011) · Bioscience Reports · doi:10.1042/bsr20110017 · Cited by 28
Biologically Active Compounds in Food Products and Their Effects on Obesity and Diabetes
Witkamp, R. F. (2010) · Elsevier eBooks · doi:10.1016/b978-008045382-8.00063-0 · Cited by 31
Anti-TNF-α antibody alleviates insulin resistance in rats with sepsis-induced stress hyperglycemia
Qu, W., Han, C., Li, M., Zhang, J., & Jiang, Z. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0742-7 · Cited by 28
Xiao, C., Giacca, A., & Lewis, G. F. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00313.2009 · Cited by 27
Yang, Z., Yang, J., Liu, W., Wu, L., Li, X., Wang, Y., Fan, X., & Cheng, Y. (2013) · Database · doi:10.1093/database/bat052 · Cited by 24
The Role of Inflammatory Pathway Genetic Variation on Maternal Metabolic Phenotypes during Pregnancy
Urbanek, M., Hayes, M. G., Lee, H., Freathy, R. M., Lowe, L. P., Ackerman, C. M., Jafari, N., Dyer, A. R., Cox, N. J., Dunger, D. B., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032958 · Cited by 25
Suzuki, Y., Enokido, Y., Yamada, K., Inaba, M., Kuwata, K., Hanada, N., Morishita, T., Mizuno, S., & Wakamatsu, N. (2017) · Oncotarget · doi:10.18632/oncotarget.17566 · Cited by 27
S-Adenosyl- L -methionine ameliorates TNFα-induced insulin resistance in 3T3-L1 adipocytes
Moon, M. K., Kim, M., Chung, S. S., Lee, H. J., Koh, S. H., Svovoda, P., Jung, M. H., Cho, Y. M., Park, Y. J., Choi, S. H., et al. (2010) · Experimental & Molecular Medicine · doi:10.3858/emm.2010.42.5.036 · Cited by 24
Aspirin inhibits serine phosphorylation of IRS-1 in muscle and adipose tissue of septic rats
Barreiro, G. C., Prattali, R. R., Caliseo, C. T., Fugiwara, F. Y., Ueno, M., Prada, P. O., Velloso, L. A., Saad, M. J. A., & Carvalheira, J. B. C. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.06.048 · Cited by 25
The metabolic syndrome and type 2 diabetes: role of the adipocyte
McPherson, R., & Jones, P. H. (2003) · Current Opinion in Lipidology · doi:10.1097/00041433-200312000-00001 · Cited by 28
Greenberg, A. S. (2003) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(03)00002-3 · Cited by 27
Chiou, W.-C., Lai, W.-H., Cai, Y.-L., Du, M.-L., Lai, H., Chen, J., Huang, H., Liu, H., & Huang, C. (2022) · Food & Function · doi:10.1039/d2fo01211a · Cited by 25
Salicylic acid: old and new implications for the treatment of type 2 diabetes?
Rena, G., & Sakamoto, K. (2014) · Diabetology International · doi:10.1007/s13340-014-0177-8 · Cited by 28
Effects of Salsalate Therapy on Recovery From Vascular Injury in Female Zucker Fatty Rats
Murthy, S. N., Desouza, C. V., Bost, N. W., Hilaire, R. S., Casey, D. B., Badejo, A. M., Dhaliwal, J. S., McGee, J., McNamara, D. B., Kadowitz, P. J., et al. (2010) · Diabetes · doi:10.2337/db09-1761 · Cited by 23
Prattali, R. R., Barreiro, G. C., Caliseo, C. T., Fugiwara, F. Y., Ueno, M., Prada, P. O., Velloso, L. A., Saad, M. J. A., & Carvalheira, J. B. C. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.04.075 · Cited by 26
RetractedModulation of insulin signalling by insulin sensitizers
Jiang, G., & Zhang, B. B. (2005) · Biochemical Society Transactions · doi:10.1042/bst0330358 · Cited by 22
Boaz, M., Lisy, L., Zandman‐Goddard, G., & Wainstein, J. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02747.x · Cited by 22
Zhang, J., Qiu, T., Jiang, L., Wang, N., Zhu, Y., Yan, R., Wang, S., Bai, J., Shi, X., Yang, G., et al. (2021) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2021.112590 · Cited by 31
Second World Congress on the Insulin Resistance Syndrome
Bloomgarden, Z. T. (2005) · Diabetes Care · doi:10.2337/diacare.28.8.2073 · Cited by 22
Inflammation and its Association with Glucose Disorders and Cardiovascular Disease
Barzilay, J. I., & Freedland, E. S. (2003) · Treatments in Endocrinology · doi:10.2165/00024677-200302020-00002 · Cited by 24
Over-the-counter analgesics normalize blood glucose and body composition in mice fed a high fat diet
Kendig, E. L., Schneider, S. N., Clegg, D. J., Genter, M. B., & Shertzer, H. G. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.05.001 · Cited by 25
Hasan, I., Rainsford, K. D., & Ross, J. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01242-9 · Cited by 21
AMP-activated protein kinase is activated by non-steroidal anti-inflammatory drugs
King-Himmelreich, T. S., Russe, O. Q., Möser, C. V., Ferreirós, N., Kynast, K. L., Knothe, C., Olbrich, K., Geißlinger, G., & Niederberger, E. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.06.001 · Cited by 21
Su, Y., Yang, S.-H., Lee, Y.-H., Wu, B., Huang, S.-C., Liu, C., Chen, S., Pan, Y., Chou, S., Chou, M., et al. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.03.009 · Cited by 22
Hashiguchi, A., Hitachi, K., Zhu, W., Tian, J., Tsuchida, K., & Komatsu, S. (2017) · Journal of Proteomics · doi:10.1016/j.jprot.2017.03.025 · Cited by 22
Bioactive lipid metabolism in platelet “first responder” and cancer biology
Marie, P. K., Kopetz, S., Hawk, E. T., Millward, S. W., Sood, A. K., Gresele, P., Overman, M. J., Honn, K. V., & Menter, D. G. (2018) · Cancer and Metastasis Reviews · doi:10.1007/s10555-018-9755-8 · Cited by 23
Adochio, R., Leitner, J. W., Hedlund, R., & Draznin, B. (2008) · Endocrinology · doi:10.1210/en.2008-0437 · Cited by 22
Basal Insulin: Beyond Glycemia
Niswender, K. D. (2011) · Postgraduate Medicine · doi:10.3810/pgm.2011.07.2301 · Cited by 22
Tumor Necrosis Factor-Like Weak Inducer of Apoptosis Attenuates the Action of Insulin in Hepatocytes
Feng, F., Wang, L., Albanese, N., Holmes, A. S., & Xia, P. (2008) · Endocrinology · doi:10.1210/en.2007-1119 · Cited by 20
Pereira, R. F., Cintra, L. T. Â., Tessarin, G. W. L., Chiba, F. Y., Mattera, M. S. D. L. C., Scaramele, N. F., Tsosura, T. V. S., Ervolino, E., Oliveira, S. H. P., & Sumida, D. H. (2017) · Journal of Endodontics · doi:10.1016/j.joen.2017.01.030 · Cited by 26
Insulin Resistance in Type 2 Diabetes
Roden, M., Petersen, K. F., & Shulman, G. I. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch13 · Cited by 25
Self-citationSomething old, something new and something very old: drugs for treating type 2 diabetes
Kaiser, D., & Oetjen, E. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12624 · Cited by 24
Characterisation of the influences of aspirin-acetylation and glycation on human plasma proteins
Finamore, F., Priego‐Capote, F., Nolli, S., Zufferey, A., Fontana, P., & Sanchez, J. (2014) · Journal of Proteomics · doi:10.1016/j.jprot.2014.11.005 · Cited by 20
Salicylic acid-based pH-sensitive hydrogels as potential oral insulin delivery systems
Demirdirek, B., & Uhrich, K. E. (2015) · Journal of drug targeting · doi:10.3109/1061186x.2015.1073293 · Cited by 21
Poly(2-ethyl-2-oxazoline) Conjugates with Salicylic Acid via Degradable Modular Ester Linkages
Bernhard, Y., Sedláček, O., Guyse, J. F. R. V., Bender, J. C. M. E., Zhong, Z., Geest, B. G. D., & Hoogenboom, R. (2020) · Biomacromolecules · doi:10.1021/acs.biomac.0c00659 · Cited by 19
Aspirin Use and Risk of Type 2 Diabetes in Apparently Healthy Men
Hayashino, Y., Hennekens, C. H., & Kurth, T. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.09.044 · Cited by 19
Prevention of Cardiovascular Complications of Diabetes Mellitus by Aspirin
Nobles‐James, C., James, E. A., & Sowers, J. R. (2004) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2004.tb00142.x · Cited by 21
Insights into the emerging cardiometabolic prevention and management of diabetes mellitus
Lastra‐González, G., Manrique, C. M., Govindarajan, G., Whaley‐Connell, A. T., & Sowers, J. R. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.13.2209 · Cited by 20
The Effects of Salsalate on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Trial
Goldfine, A. B., Fonseca, V., Jablonski, K. A., Pyle, L., Staten, M. A., Shoelson, S. E., & for the TINSAL-T2D (Targeting Inflammation Using Salsalate in Type 2 Diabetes) Study Team* (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-6-201003160-00004 · Cited by 388
Self-citationBolnick, A. D., Abdulhasan, M. A., Kilburn, B. A., Xie, Y., Howard, M., Andresen, P., Shamir, A. M., Dai, J., Puscheck, E. E., & Rappolee, D. A. (2016) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-016-0735-z · Cited by 18
Li, C. B., Li, X. X., Chen, Y. G., Gao, H. Q., Bu, P. L., Zhang, Y., & Ji, X. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067530 · Cited by 21
Glucose-Lowering Effects of Sulfasalazine in Type 2 Diabetes
Haas, R. M., Li, P., & Chu, J. W. (2005) · Diabetes Care · doi:10.2337/diacare.28.9.2238 · Cited by 18
Yan, S., Tang, J., Zhang, Y., Wang, Y., Zuo, S., Shen, Y., Zhang, Q., Chen, D., Yu, Y., Wang, K., et al. (2016) · Hepatology · doi:10.1002/hep.28928 · Cited by 23
Evaluation of diabetes determinants in woolly monkeys (Lagothrix lagotricha)
Heugten, K. A., Burns, R. B., Verstegen, M. W. A., Jansen, W. L., Ferket, P. R., & van Heugten, E. (2007) · Journal of Animal Physiology and Animal Nutrition · doi:10.1111/j.1439-0396.2007.00679.x · Cited by 17
A meta-analysis of salicylates for type 2 diabetes mellitus
Fang, F., Lu, Y., Ma, D., Du, T., Shao, S., & Yu, X. (2013) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-013-1063-5 · Cited by 17
Review: Aspirin and Diabetes Mellitus: revisiting an old player
Manrique, C. M., Lastra, G., Palmer, J. C., Gardner, M., & Sowers, J. R. (2008) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944707088185 · Cited by 17
Bernal-López, M. R., Llorente‐Cortés, V., Calleja, F., Lopez-Carmona, M. D., Mayas, M. D., Gómez-Huelgas, R., Badimón, L., & Tinahones, F. J. (2011) · Acta Diabetologica · doi:10.1007/s00592-011-0337-2 · Cited by 16
PGE2 synthesis and signaling in the liver physiology and pathophysiology: An update
Qiang, E., & Xu, H. (2024) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2024.106875 · Cited by 19
The Epidemic of Type 2 Diabetes Mellitus: Its Links to Obesity, Insulin Resistance, and Lipotoxicity
Cusi, K. J. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-260-1_1 · Cited by 19
van Dielen, F. M. H., Nijhuis, J., Rensen, S. S., Schaper, N. C., Wiebolt, J., Koks, A., Prakken, F. J., Buurman, W. A., & Greve, J. W. M. (2009) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2009.11.011 · Cited by 16
Zhou, Y., Peng, H., Liu, Z., Zhang, K. K., Jendrusch, C., Drake, M., Hao, Y., & Xie, L. (2018) · Laboratory Investigation · doi:10.1038/s41374-018-0144-2 · Cited by 15
Epidemiology and Geography of Type 2 Diabetes Mellitus
Qiao, Q., Williams, D. E., Imperatore, G., Narayan, K. M. V., & Tuomilehto, J. O. (2004) · Wiley eBooks · doi:10.1002/0470862092.d0104 · Cited by 17
Macrophages: friend or foe in diabetes pathogenesis and therapy
Grimes, R. N., Orecchioni, M., & Quesada‐Masachs, E. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1625391 · Cited by 15
Association of metformin, aspirin, and cancer incidence with mortality risk in adults with diabetes
Orchard, S. G., Lockery, J. E., Broder, J. C., Ernst, M. E., Espinoza, S. E., Gibbs, P., Wolfe, R. S., Polekhina, G., Zoungas, S., Loomans-Kropp, H. A., et al. (2023) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkad017 · Cited by 18
Diabetes disease progression in Goto-Kakizaki rats: effects of salsalate treatment
Almon, R. R., Wang, X., DuBois, D. C., Cao, Y., & Jusko, W. J. (2014) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s65818 · Cited by 15
Coe, L. M., Denison, J. D., & McCabe, L. R. (2011) · Cellular Physiology and Biochemistry · doi:10.1159/000335806 · Cited by 19
Pathogenesis of Type 2 Diabetes Mellitus
DeFronzo, R. A. (2018) · Endocrinology · doi:10.1007/978-3-319-45015-5_8 · Cited by 16
Role of the Adipocyte in Metabolism and Endocrine Function
Ravussin, É., & Smith, S. R. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00036-6 · Cited by 18
Pathogenesis of type 2 diabetes mellitus
DeFronzo, R. A. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch25 · Cited by 37
Muldoon, K. A., McLean, C., El‐Chaâr, D., Corsi, D. J., Rybak, N., Dagvadorj, A., Guo, Y., White, R. R., Dingwall‐Harvey, A. L. J., Gaudet, L., et al. (2023) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2023.2200879 · Cited by 16
Clinical Pharmacology in Sarcoidosis: How to Use and Monitor Sarcoidosis Medications
Kwon, S., & Judson, M. A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13051250 · Cited by 14
Molecular Mechanisms of Insulin Resistance
Draznin, B. (2019) · Contemporary Endocrinology · doi:10.1007/978-3-030-25057-7_4 · Cited by 15
Insulin and disorders of behavioural flexibility
Sullivan, M., Fernández‐Aranda, F., Camacho‐Barcia, L., Harkin, A., Macrì, S., Mora‐Maltas, B., Jiménez‐Múrcia, S., O’Leary, A., Ottomana, A. M., Presta, M., et al. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105169 · Cited by 17
High dose of aspirin moderates diabetes-induced changes of heart glycogen/glucose metabolism in rats
Dervisevik, M., Dinevska-Ќovkarovska, S., Dimitrovska, M. J., Cipanovska, N., & Miova, B. (2014) · The Journal of Physiological Sciences · doi:10.1007/s12576-014-0335-6 · Cited by 14
TarNet: An Evidence-Based Database for Natural Medicine Research
Hu, R., Ren, G., Sun, G., & Sun, X. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157222 · Cited by 14
The Mechanisms of Insulin Action
White, M. F., & Copps, K. D. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00033-0 · Cited by 13
Emerging therapeutic targets for NASH: key innovations at the preclinical level
Horn, P., & Newsome, P. N. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1728742 · Cited by 13
Singh, V., Jain, M. K., Prakash, P., Misra, A., Khanna, V., Tiwari, R. L., Keshari, R. S., Singh, S. V., Dikshit, M., & Barthwal, M. K. (2011) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-010-0065-z · Cited by 12
Aspirin, a potential GLUT1 inhibitor in a vascular endothelial cell line
Hu, Y.-B., Lou, X., Wang, R., Sun, C., Liu, X., Liu, S., Wang, Z., & Chen, N. (2019) · Open Medicine · doi:10.1515/med-2019-0062 · Cited by 11
Pascual, G., Ricote, M., & Hevener, A. L. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.11.1503 · Cited by 12
Insulin Resistance in Type 2 Diabetes
Roden, M., Petersen, K. F., & Shulman, G. I. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch17 · Cited by 22
Self-citationGonzález, F., Mather, K. J., Considine, R. V., Abdelhadi, O. A., & Acton, A. J. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00228.2020 · Cited by 16
Berberine: A Comprehensive Review on its Isolation, Biosynthesis, Chemistry and Pharmacology
Ali, F., Alom, S., & Zaman, K. (2021) · Asian Journal of Chemistry · doi:10.14233/ajchem.2021.23365 · Cited by 13
Regulation of Appetite and Insulin Signaling in Inflammatory States
TELI, T., XANTHAKI, D., & Karalis, K. P. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1367.022 · Cited by 13
Chronic Inflammation in the Metabolic Syndrome: Emphasis on Adipose Tissue
Monteiro, R. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9701-0_4 · Cited by 16
Investigation of salicylate hepatic responses in comparison with chemical analogues of the drug
Cameron, A., Logie, L., Patel, K., Bacon, S., Forteath, C., Harthill, J. E., Roberts, A. J., Sutherland, C. D., Stewart, D., Viollet, B., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.04.015 · Cited by 11
Low dose aspirin associated with greater bone mineral density in older adults
Liu, H., Xiao, X., Shi, Q., Tang, X., & Tian, Y. (2022) · Scientific Reports · doi:10.1038/s41598-022-19315-0 · Cited by 14
Pathogenesis of Type 2 Diabetes Mellitus
DeFronzo, R. A. (2018) · Endocrinology · doi:10.1007/978-3-319-27317-4_8-1 · Cited by 13
Schwanstecher, C., & Schwanstecher, M. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-17214-4_1 · Cited by 13
Zhang, J., Wang, F., Zhong, H., Pi, J., Chen, G., & Chen, Z. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118342 · Cited by 12
Aspirin Suppresses Hepatic Glucagon Signaling Through Decreasing Production of Thromboxane A2
Dai, Y., Xu, R., Wu, G., Yin, Z., Zhang, H., Li, H., & Chen, W. (2023) · Endocrinology · doi:10.1210/endocr/bqac217 · Cited by 12
Salsalate treatment improves glycemia without altering adipose tissue in nondiabetic obese hispanics
Alderete, T. L., Sattler, F. R., Richey, J. M., Allayee, H., Mittelman, S. D., Sheng, X., Tucci, J., Gyllenhammer, L. E., Grant, E. G., & Goran, M. I. (2015) · Obesity · doi:10.1002/oby.20991 · Cited by 10
Perioperative Heart-Brain Axis Protection in Obese Surgical Patients: The Nutrigenomic Approach
Agrimi, J., Baroni, C., Anakor, E., & Lionetti, V. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666181015145225 · Cited by 10
Metadata
- Authors
- Hundal, R. S., Petersen, K. F., Mayerson, A. B., Randhawa, P. S., Inzucchi, S., Shoelson, S. E., & Shulman, G. I.
- Affiliations
- Yale University (US)
- Joslin Diabetes Center (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Shulman, Gerald I.
- Venue
- Journal of Clinical Investigation
- Published
- 2002-05-15
- Volume
- 109
- Issue
- 10
- Pages
- 1321-1326
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W4246592598
- Cited by
- 557
- References
- 24
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 21 · 2023: 17 · 2022: 12 · 2021: 11 · 2020: 19 · 2019: 12 · 2018: 21 · 2017: 17 · 2016: 24 · 2015: 32 · 2014: 33 · 2013: 24 · 2012: 24
- FWCI
- 16.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Funders
- Yale University
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- high-dose aspirin, salicylates, type 2 diabetes, glucose metabolism, insulin resistance, IKKβ, serine kinase, fatty acid signaling, glucose turnover, hepatic glucose production, insulin-stimulated glucose uptake, hyperinsulinemic-euglycemic clamp, mixed meal tolerance test, C-reactive protein, triglycerides, cholesterol
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.